Raju Shilpa R, Balakrishnan Sreenath, Kollimada Somanna, Chandrashekara K N, Jampani Aruna
Department of Biotechnology, REVA University, Bengaluru, India.
Department of Mechanical Engineering, Indian Institute of Science, Bengaluru, India.
Heliyon. 2020 Oct 5;6(10):e05088. doi: 10.1016/j.heliyon.2020.e05088. eCollection 2020 Oct.
(AN), which is known to have antimicrobial, antioxidant, antiulcer, and anti-asthmatic properties, has been recently shown to have anti-cancer activity. However, the mechanism responsible for the anti-cancer property and its effect on cellular properties and functions are not known.
We have characterized the biochemical and biomechanical properties of MDA-MB-231 cells treated with the methanolic extract from AN.
We show that AN-treatment decreases cell-eccentricity, increases expression of actin and microtubules, and do not affect cell-area. Increased expression of cytoskeletal proteins is known to change the mechanical properties of the cells, which was confirmed using micropipette aspiration and Atomic Force Microscopy. We identified the upregulation of the tumorigenic pathway (TGF-β) leading to activation of Rho-A as the molecular mechanism responsible for actin upregulation. Since the initial stages of TGF-β upregulation are known to suppress tumor growth by activating apoptosis, we hypothesized that the mechanism of cell death due to AN-treatment is through TGF-β activation. We have validated this hypothesis by partially recuing cell death through inhibition of TGF-β using Alk-5.
In summary, our study reveals the mechanism of action of using a synergy between biochemical and biomechanical techniques.
已知(AN)具有抗菌、抗氧化、抗溃疡和抗哮喘特性,最近还显示出具有抗癌活性。然而,其抗癌特性的作用机制及其对细胞特性和功能的影响尚不清楚。
我们对用AN甲醇提取物处理的MDA-MB-231细胞的生化和生物力学特性进行了表征。
我们发现,AN处理可降低细胞偏心率,增加肌动蛋白和微管的表达,且不影响细胞面积。已知细胞骨架蛋白表达增加会改变细胞的力学特性,这通过微量移液管抽吸和原子力显微镜得到了证实。我们确定致癌途径(TGF-β)的上调导致Rho-A激活是肌动蛋白上调的分子机制。由于已知TGF-β上调的初始阶段通过激活凋亡来抑制肿瘤生长,我们推测AN处理导致细胞死亡的机制是通过TGF-β激活。我们通过使用Alk-5抑制TGF-β部分挽救细胞死亡,验证了这一假设。
总之,我们的研究揭示了利用生化和生物力学技术之间的协同作用的作用机制。